CoChat

GLP-1/Glucagon Coagonism Restores Leptin Responsiveness in Obese Mice Chronically Maintained on an Obesogenic Diet

Open access
Clemmensen, Christoffer, Chabenne, Joseph, Finan, Brian, Sullivan, Lorraine, Fischer, Katrin, Küchler, Daniela, Sehrer, Laura, Ograjsek, Teja, Hofmann, Susanna M., Schriever, Sonja C., Pfluger, Paul T., Pinkstaff, Jason, Tschöp, Matthias H., DiMarchi, Richard, Müller, Timo D. · 2014 · Diabetes
Cited by 136

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

We recently reported restoration of leptin responsiveness in diet-induced obese (DIO) mice using a pharmacologically optimized, polyethylene-glycolated (PEG)-leptin analog in combination with exendin-4 or FGF21. However, the return of leptin action required discontinuation of high-fat diet (HFD) exposure. Here we assess whether a single peptide possessing balanced coagonism at the glucagon-like peptide 1 (GLP-1) and glucagon receptors can restore leptin responsiveness in DIO mice maintained on a HFD. DIO mice were treated with PEG-GLP-1/glucagon (30 nmol/kg every fourth day) to induce an ∼15% body weight loss, upon which they were randomized to continue PEG-GLP-1/glucagon therapy or reassigned to receive supplemental daily PEG-leptin (185 nmol/kg/day). The addition of PEG-leptin to PEG-GLP-1/glucagon resulted in an ∼18% greater weight loss as compared with PEG-GLP-1/glucagon alone and was accompanied by further decreases in food intake and improved glucose and lipid metabolism. The beneficial effect of PEG-leptin supplementation occurred after an initial body weight loss similar to what we previously reported following reduced dietary fat along with PEG-leptin and exendin-4 or FGF21 cotreatment. In summary, we report that GLP-1/glucagon coagonism restores leptin responsiveness in mice maintained on a HFD, thus emphasizing the translational value of this polypharmacotherapy for the treatment of obesity and diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db13-1609

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 16

  1. Zhang, 1994, Positional cloning of the mouse obese gene and its human homologue, Nature, 372, 425, 10.1038/372425a0 · DOI · Paper page
  2. Halaas, 1995, Weight-reducing effects of the plasma protein encoded by the obese gene, Science, 269, 543, 10.1126/science.7624777 · DOI · Paper page
  3. Heymsfield, 1999, Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial, JAMA, 282, 1568, 10.1001/jama.282.16.1568 · DOI · Paper page
  4. Scarpace, 2009, Leptin resistance: a prediposing factor for diet-induced obesity, Am J Physiol Regul Integr Comp Physiol, 296, R493, 10.1152/ajpregu.90669.2008 · DOI · Paper page
  5. Trevaskis, 2010, Interaction of leptin and amylin in the long-term maintenance of weight loss in diet-induced obese rats, Obesity (Silver Spring), 18, 21, 10.1038/oby.2009.187 · DOI · Paper page
  6. Sadry, 2013, Emerging combinatorial hormone therapies for the treatment of obesity and T2DM, Nat Rev Endocrinol, 9, 425, 10.1038/nrendo.2013.47 · DOI · Paper page
  7. Coppari, 2012, Leptin revisited: its mechanism of action and potential for treating diabetes, Nat Rev Drug Discov, 11, 692, 10.1038/nrd3757 · DOI · Paper page
  8. Vasselli, 2013, Dietary components in the development of leptin resistance, Adv Nutr, 4, 164, 10.3945/an.112.003152 · DOI
  9. Vasselli, 2012, The role of dietary components in leptin resistance, Adv Nutr, 3, 736, 10.3945/an.112.002659 · DOI
  10. Vasselli, 2008, Fructose-induced leptin resistance: discovery of an unsuspected form of the phenomenon and its significance. Focus on “Fructose-induced leptin resistance exacerbates weight gain in response to subsequent high-fat feeding,” by Shapiro et al, Am J Physiol Regul Integr Comp Physiol, 295, R1365, 10.1152/ajpregu.90674.2008 · DOI
  11. Vasselli, 2001, Behavioral and biological determinants of leptin resistance, Appetite, 37, 115, 10.1006/appe.2001.0418 · DOI
  12. Thaler, 2012, Obesity is associated with hypothalamic injury in rodents and humans, J Clin Invest, 122, 153, 10.1172/JCI59660 · DOI · Paper page
  13. Wang, 2001, Overfeeding rapidly induces leptin and insulin resistance, Diabetes, 50, 2786, 10.2337/diabetes.50.12.2786 · DOI · Paper page
  14. Beiroa, 2013, Heterozygous deficiency of endoglin decreases insulin and hepatic triglyceride levels during high fat diet, PLoS ONE, 8, e54591, 10.1371/journal.pone.0054591 · DOI
  15. Banks, 2004, Triglycerides induce leptin resistance at the blood-brain barrier, Diabetes, 53, 1253, 10.2337/diabetes.53.5.1253 · DOI · Paper page
  16. Shapiro, 2008, Fructose-induced leptin resistance exacerbates weight gain in response to subsequent high-fat feeding, Am J Physiol Regul Integr Comp Physiol, 295, R1370, 10.1152/ajpregu.00195.2008 · DOI · Paper page

Cited by

Metadata

Authors
Clemmensen, C., Chabenne, J., Finan, B., Sullivan, L., Fischer, K., Küchler, D., Sehrer, L., Ograjsek, T., Hofmann, S. M., Schriever, S. C., Pfluger, P. T., Pinkstaff, J., Tschöp, M. H., DiMarchi, R., & Müller, T. D.
Venue
Diabetes
Published
2014-03-13
Volume
63
Issue
4
Pages
1422-1427
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2041738999
Cited by
136
References
7
FWCI
5.65
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.